Valion Bio Inc (VBIO) — Cash Flow-to-Debt Ratio
Valion Bio Inc (VBIO) has a Cash Flow-to-Debt Ratio of -0.26x as of June 2026, meaning its operating cash flow of $-5.28 Million could theoretically repay 0% of its total liabilities ($20.59 Million) in one year. See Valion Bio Inc (VBIO) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Valion Bio Inc Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Valion Bio Inc across 14 annual periods. For the full cash flow conversion analysis, see Valion Bio Inc (VBIO) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Valion Bio Inc (2010–2025)
Year-by-year debt coverage analysis for Valion Bio Inc. Check earnings quality score of Valion Bio Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.47x | $-7.00 Million | $14.81 Million | ▲ +97.8% |
| 2024 | -21.05x | $-5.72 Million | $272.00K | ▼ -290.0% |
| 2023 | -5.40x | $-8.51 Million | $1.58 Million | ▼ -35.8% |
| 2022 | -3.97x | $-8.92 Million | $2.25 Million | ▲ +91.7% |
| 2020 | -48.00x | $-1.61 Million | $33.44K | ▼ -1617.6% |
| 2019 | -2.79x | $-3.59 Million | $1.28 Million | ▲ +65.8% |
| 2017 | -8.16x | $-2.89 Million | $353.52K | ▼ -372.1% |
| 2016 | -1.73x | $-1.38 Million | $800.65K | ▲ +33.0% |
| 2015 | -2.58x | $-1.69 Million | $652.96K | ▼ -59.2% |
| 2014 | -1.62x | $-2.50 Million | $1.54 Million | ▼ -16.3% |
| 2013 | -1.39x | $-2.13 Million | $1.53 Million | ▲ +6.0% |
| 2012 | -1.48x | $-1.65 Million | $1.11 Million | ▼ -468.0% |
| 2011 | -0.26x | $-26.12K | $100.00K | ▼ -42720.8% |
| 2010 | 0.00x | $-31.54K | $51.70 Million | — |